Episode

Episode 66: Mark Abelson, Founder of Ora Clinical

Podcast: Few & Far Between: How Biotech Gets Built
Published: Dec 16, 2025
Duration seconds: 2607
Processing state: not_requested
Canonical source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-66-mark-abelson-founder-of-ora-clinical
Audio: https://dts.podtrac.com/redirect.mp3/episodes.castos.com/6026d270a471b8-76273800/2290812/c1e-o3p3nb28qg5im2roj-jpn5g0rwi7p3-bkrcrf.mp3
JSON: /v1/public/podcasts/few-far-between-how-biotech-gets-built-4067896/episodes/episode-66-mark-abelson-founder-of-ora-clinical
Markdown: /podcast/few-far-between-how-biotech-gets-built-4067896/episode-66-mark-abelson-founder-of-ora-clinical.md

Actions

POST https://stenobird.com/v1/public/podcasts/few-far-between-how-biotech-gets-built-4067896/episodes/episode-66-mark-abelson-founder-of-ora-clinical/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896/episode-66-mark-abelson-founder-of-ora-clinical.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Are clinical trial protocols a true art form? Find out in a new episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien welcomes guest Mark Ableson, founder of Ora Clinical and CRO pioneer. We'll be discussing exploratory endpoints, what to learn from failed trails, and essential factors in choosing a clinical site location. Listen today!